Trial · NCT00835003
Timing of Planned Caesarean Section and Morbidity of the Newborn
NCT00835003, Not applicable, Completed, Aarhus University Hospital; results first posted 2014-07-03
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Timing of Planned Caesarean Section and Morbidity of the Newborn. Trials, record NCT00835003. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00835003
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Timing of Planned Caesarean Section and Morbidity of the Newborn
- NCT number
- NCT00835003
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,273 participants, actual
- Lead sponsor
- Aarhus University Hospital
- Conditions
- Respiratory Disorders, Intensive Care, Neonatal
- Interventions
- Elective caesarean section, Elective caesarean section
- First posted
- 2009-02-03
- Last updated
- 2014-07-03
- Results first posted
- 2014-07-03
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Neonatal Admission After Elective Caesarean Section | 48 hours | |
| Secondary | Neonatal Diagnoses | 30 days | |
| Secondary | Duration of Neonatal Treatment With Ventilator, CPAP, Oxygen and/or Antibiotics | 30 days | |
| Secondary | Maternal Haemorrhage in ml or Organ Laceration During Caesarean Section. | 30 days | |
| Secondary | Maternal Fever, Wound Infection, Need of Wound Operative Revision and Antibiotics, Duration of Admission | 30 days | |
| Secondary | Maternal Satisfaction With Timing of Elective Caesarean Section | 2 months | |
| Secondary | Post Partum Depression | 2 months | |
| Secondary | Pediatric Admission and Morbidity | 2 months post partum | |
| Secondary | Pediatric Admission and Morbidity | From birth until 2 years of age |
Source ClinicalTrials.gov
Outcomes9
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Neonatal Admission After Elective Caesarean Section | 48 hours | participants | NUMBER | |
| SECONDARY | Neonatal Diagnoses | 30 days | |||
| SECONDARY | Duration of Neonatal Treatment With Ventilator, CPAP, Oxygen and/or Antibiotics | 30 days | |||
| SECONDARY | Maternal Haemorrhage in ml or Organ Laceration During Caesarean Section. | 30 days | |||
| SECONDARY | Maternal Fever, Wound Infection, Need of Wound Operative Revision and Antibiotics, Duration of Admission | 30 days | |||
| SECONDARY | Maternal Satisfaction With Timing of Elective Caesarean Section | 2 months | |||
| SECONDARY | Post Partum Depression | 2 months | |||
| SECONDARY | Pediatric Admission and Morbidity | 2 months post partum | |||
| SECONDARY | Pediatric Admission and Morbidity | From birth until 2 years of age |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Neonatal Admission After Elective Caesarean Section | 38 Weeks Group | 88 | participants | ||
| Neonatal Admission After Elective Caesarean Section | 39 Weeks Group | 76 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 38 Weeks Group | 636 | |
| Overall Study | STARTED | 39 Weeks Group | 638 | |
| Overall Study | COMPLETED | 38 Weeks Group | 636 | |
| Overall Study | COMPLETED | 39 Weeks Group | 638 | |
| Overall Study | NOT COMPLETED | 38 Weeks Group | 0 | |
| Overall Study | NOT COMPLETED | 39 Weeks Group | 0 |
Source ClinicalTrials.gov
Adverse events4
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Fetal death | Pregnancy, puerperium and perinatal conditions | 38 Weeks Group | 1 | 636 | |
| serious | Fetal death | Pregnancy, puerperium and perinatal conditions | 39 Weeks Group | 1 | 638 | |
| serious | Neonatal death | Respiratory, thoracic and mediastinal disorders | 38 Weeks Group | 0 | 636 | |
| serious | Neonatal death | Respiratory, thoracic and mediastinal disorders | 39 Weeks Group | 1 | 638 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | 38 Weeks Group | ||
| Total, all-cause mortality | 39 Weeks Group | ||
| Total, other adverse events | 38 Weeks Group | 0 | 636 |
| Total, other adverse events | 39 Weeks Group | 0 | 638 |
| Total, serious adverse events | 38 Weeks Group | 1 | 636 |
| Total, serious adverse events | 39 Weeks Group | 2 | 638 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| 38 Weeks Group vs 39 Weeks Group: Neonatal Admission After Elective Caesarean Section | Trial comparisons |
| 38 Weeks Group vs 39 Weeks Group: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00835003
GET https://conductscience.org/api/trials/v1/NCT00835003/registered